Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest update is out from Charmacy Pharmaceutical Co., Ltd. Class H ( (HK:2289) ).
Charmacy Pharmaceutical has declared a final ordinary dividend of RMB 0.3 per share for the financial year ended 31 December 2025, with shareholder approval obtained on 22 May 2026. The dividend will be paid in Hong Kong dollars at HKD 0.343531 per share based on an exchange rate of RMB 1 to HKD 1.145103, with an ex-dividend date of 27 May 2026 and payment scheduled for 25 June 2026.
The company detailed the timetable for entitlement, including book closure from 29 May to 5 June 2026 and a record date of 5 June 2026, and outlined withholding tax arrangements for resident and non-resident shareholders. These tax treatments, including a 10% rate for non-resident enterprises and individuals and 20% for PRC-resident individuals, clarify net dividend expectations and provide transparency for investors regarding after-tax returns on the declared payout.
More about Charmacy Pharmaceutical Co., Ltd. Class H
Charmacy Pharmaceutical Co., Ltd. is a Hong Kong-listed pharmaceutical company operating under stock code 02289. It focuses on the distribution and sale of pharmaceutical products, serving healthcare market participants and investors in the Greater China region.
Average Trading Volume: 1,500
Technical Sentiment Signal: Sell
Current Market Cap: HK$628.6M
For a thorough assessment of 2289 stock, go to TipRanks’ Stock Analysis page.